{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:38:21Z","timestamp":1788777501822,"version":"build-2803163510"},"reference-count":63,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Type 2N von Willebrand disease is caused by mutations in the factor VIII (FVIII) binding site of von Willebrand factor (VWF), resulting in dysfunctional VWF with defective binding capacity for FVIII. We developed a novel type 2N mouse model using CRISPR\/Cas9 technology. In homozygous VWF2N\/2N mice, plasma VWF levels were normal (1167 \u00b1 257 mU\/mL), but the VWF was completely incapable of binding FVIII, resulting in 53 \u00b1 23 mU\/mL of plasma FVIII levels that were similar to those in VWF-deficient (VWF\u2212\/\u2212) mice. When wild-type human or mouse VWF was infused into VWF2N\/2N mice, endogenous plasma FVIII was restored, peaking at 4 to 6 hours post-infusion, demonstrating that FVIII expressed in VWF2N mice is viable but short-lived unprotected in plasma due to dysfunctional 2N VWF. The whole blood clotting time and thrombin generation were impaired in VWF2N\/2N but not in VWF\u2212\/\u2212 mice. Bleeding time and blood loss in VWF2N\/2N mice were similar to wild-type mice in the lateral tail vein or ventral artery injury model. However, VWF2N\/2N mice, but not VWF\u2212\/\u2212 mice, lost a significant amount of blood during the primary bleeding phase after a tail tip amputation injury model, indicating that alternative pathways can at least partially restore hemostasis when VWF is absent. In summary, we have developed a novel mouse model by gene editing with both the pathophysiology and clinical phenotype found in severe type 2N patients. This unique model can be used to investigate the biological properties of VWF\/FVIII association in hemostasis and beyond.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006353","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T22:04:28Z","timestamp":1641938668000},"page":"2778-2790","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["A novel mouse model of type 2N VWD was developed by CRISPR\/Cas9 gene editing and recapitulates human type 2N VWD"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1548-0708","authenticated-orcid":false,"given":"Qizhen","family":"Shi","sequence":"first","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI;"},{"name":"Departments of Pediatrics, Physiology, and Genetics, Medical College of Wisconsin, Milwaukee, WI;"},{"name":"Children\u2019s Research Institute, Milwaukee, WI; and"},{"name":"MACC Fund Research Center, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot A.","family":"Fahs","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy G.","family":"Mattson","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyin","family":"Yu","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI;"},{"name":"Departments of Pediatrics, Physiology, and Genetics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal L.","family":"Perry","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Morateck","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn A.","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI;"},{"name":"Departments of Pediatrics, Physiology, and Genetics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Rapten","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Weiler","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI;"},{"name":"Departments of Pediatrics, Physiology, and Genetics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI;"},{"name":"Departments of Pediatrics, Physiology, and Genetics, Medical College of Wisconsin, Milwaukee, WI;"},{"name":"Children\u2019s Research Institute, Milwaukee, WI; and"},{"name":"MACC Fund Research Center, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"issue":"2","key":"2022050215222199400_B1","first-page":"201","article-title":"Regulation of factor VIII expression and activity by von Willebrand factor","volume":"82","author":"Kaufman","year":"1999","journal-title":"Thromb Haemost."},{"issue":"3","key":"2022050215222199400_B2","first-page":"1233","article-title":"Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells","volume":"9","author":"Kaufman","year":"1989","journal-title":"Mol Cell Biol."},{"issue":"6","key":"2022050215222199400_B3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-0038-1648506","article-title":"The structure and function of von Willebrand factor","volume":"67","author":"Ruggeri","year":"1992","journal-title":"Thromb Haemost."},{"issue":"3","key":"2022050215222199400_B4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00043426-200005000-00017","article-title":"Interactions between von Willebrand factor and Factor VIII: where did they first meet","volume":"22","author":"Montgomery","year":"2000","journal-title":"J Pediatr Hematol Oncol."},{"issue":"1","key":"2022050215222199400_B5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol."},{"issue":"5","key":"2022050215222199400_B6","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2002-03-0789","article-title":"The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF","volume":"100","author":"Rosenberg","year":"2002","journal-title":"Blood."},{"issue":"5","key":"2022050215222199400_B7","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1182\/blood.V96.5.1808","article-title":"von Willebrand factor storage and multimerization: 2 independent intracellular processes","volume":"96","author":"Haberichter","year":"2000","journal-title":"Blood."},{"key":"2022050215222199400_B8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1538-7836.2009.03375.x","article-title":"von Willebrand factor assembly and secretion","volume":"7","author":"Sadler","year":"2009","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2022050215222199400_B9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood."},{"key":"2022050215222199400_B10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2516.2008.01848.x","article-title":"Function of von Willebrand factor in haemostasis and thrombosis","volume":"14","author":"Reininger","year":"2008","journal-title":"Haemophilia."},{"issue":"12","key":"2022050215222199400_B11","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/01.RES.0000267878.97021.ab","article-title":"Adhesion mechanisms in platelet function","volume":"100","author":"Ruggeri","year":"2007","journal-title":"Circ Res."},{"issue":"2","key":"2022050215222199400_B12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00001721-199104000-00017","article-title":"von Willebrand factor and platelet interactions with the vessel wall","volume":"2","author":"Fressinaud","year":"1991","journal-title":"Blood Coagul Fibrinolysis."},{"issue":"1","key":"2022050215222199400_B13","first-page":"178","article-title":"The vascular biology of the glycoprotein Ib-IX-V complex","volume":"86","author":"Berndt","year":"2001","journal-title":"Thromb Haemost."},{"key":"2022050215222199400_B14","first-page":"s3","article-title":"Role of von Willebrand factor in the haemostasis","volume":"9","author":"Peyvandi","year":"2011","journal-title":"Blood Transfus."},{"issue":"2","key":"2022050215222199400_B15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia."},{"key":"2022050215222199400_B16","author":"Montgomery","year":"2009"},{"issue":"16","key":"2022050215222199400_B17","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood."},{"issue":"16","key":"2022050215222199400_B18","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2010-03-272419","article-title":"Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A","volume":"116","author":"Shi","year":"2010","journal-title":"Blood."},{"issue":"1","key":"2022050215222199400_B19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V60.1.201.201","article-title":"A variant of von Willebrand\u2019s disease with abnormal expression of factor VIII procoagulant activity","volume":"60","author":"Montgomery","year":"1982","journal-title":"Blood."},{"issue":"1","key":"2022050215222199400_B20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.V75.1.20.20","article-title":"A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF\/FVIII interaction","volume":"75","author":"Mazurier","year":"1990","journal-title":"Blood."},{"issue":"4","key":"2022050215222199400_B21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jth.15247","article-title":"Von Willebrand disease type 2N: an update","volume":"19","author":"Seidizadeh","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2022050215222199400_B22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/beha.2001.0138","article-title":"Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology","volume":"14","author":"Mazurier","year":"2001","journal-title":"Best Pract Res Clin Haematol."},{"issue":"6","key":"2022050215222199400_B23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V58.6.1075.1075","article-title":"Platelet von Willebrand\u2019s antigen II: active release by aggregating agents and a marker of platelet release reaction in\u00a0vivo","volume":"58","author":"Scott","year":"1981","journal-title":"Blood."},{"issue":"29","key":"2022050215222199400_B24","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.1016\/S0021-9258(18)54972-3","article-title":"Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease","volume":"266","author":"Kroner","year":"1991","journal-title":"J Biol Chem."},{"issue":"4","key":"2022050215222199400_B25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<302::AID-AJH9>3.0.CO;2-#","article-title":"Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII","volume":"51","author":"Rick","year":"1996","journal-title":"Am J Hematol."},{"issue":"9","key":"2022050215222199400_B26","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood.V89.9.3263","article-title":"A patient with type 2N von Willebrand disease is heterozygous for a new mutation: Gly22Glu. Demonstration of a defective expression of the second allele by the use of monoclonal antibodies","volume":"89","author":"Gu","year":"1997","journal-title":"Blood."},{"issue":"6","key":"2022050215222199400_B27","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/bjh.14028","article-title":"von Willebrand disease type1\/type 2N compound heterozygotes: diagnostic and management challenges","volume":"176","author":"Perez Botero","year":"2017","journal-title":"Br J Haematol."},{"issue":"8","key":"2022050215222199400_B28","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/jth.13749","article-title":"Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice","volume":"15","author":"Swystun","year":"2017","journal-title":"J Thromb Haemost."},{"issue":"26","key":"2022050215222199400_B29","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2013-07-517086","article-title":"Solution structure of the major factor VIII binding region on von Willebrand factor","volume":"123","author":"Shiltagh","year":"2014","journal-title":"Blood."},{"issue":"3","key":"2022050215222199400_B30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nbt.3481","article-title":"Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA","volume":"34","author":"Richardson","year":"2016","journal-title":"Nat Biotechnol."},{"issue":"16","key":"2022050215222199400_B31","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"issue":"7","key":"2022050215222199400_B32","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI28416","article-title":"Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest."},{"issue":"8","key":"2022050215222199400_B33","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1538-7836.2012.04791.x","article-title":"Lentivirus-mediated platelet gene therapy of murine hemophilia\u00a0A with pre-existing anti-factor\u00a0VIII immunity","volume":"10","author":"Kuether","year":"2012","journal-title":"J Thromb Haemost."},{"issue":"7","key":"2022050215222199400_B34","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/jth.13001","article-title":"The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies","volume":"13","author":"Shi","year":"2015","journal-title":"J Thromb Haemost."},{"issue":"8","key":"2022050215222199400_B35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood-2009-11-255612","article-title":"Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood."},{"issue":"12","key":"2022050215222199400_B36","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/jth.13169","article-title":"Comparison of platelet-derived and plasma factor VIII efficacy using a novel native whole blood thrombin generation assay","volume":"13","author":"Baumgartner","year":"2015","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022050215222199400_B37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/hae.12907","article-title":"Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice: characterization of two novel FVIII molecules","volume":"22","author":"Johansen","year":"2016","journal-title":"Haemophilia."},{"issue":"1","key":"2022050215222199400_B38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/rth2.12280","article-title":"A rat model of severe VWD by elimination of the VWF gene using CRISPR\/Cas9","volume":"4","author":"Garcia","year":"2019","journal-title":"Res Pract Thromb Haemost."},{"issue":"4","key":"2022050215222199400_B39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2516.2011.02735.x","article-title":"Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice","volume":"18","author":"Shi","year":"2012","journal-title":"Haemophilia."},{"key":"2022050215222199400_B40","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/asheducation-2016.1.678","article-title":"Diagnosing von Willebrand disease: genetic analysis","volume":"2016","author":"Goodeve","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"2","key":"2022050215222199400_B41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/hae.13175","article-title":"Molecular diagnosis of von Willebrand disease","volume":"23","author":"Baronciani","year":"2017","journal-title":"Haemophilia."},{"issue":"1","key":"2022050215222199400_B42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/hae.13366","article-title":"Type 2N von Willebrand disease: characterization and diagnostic difficulties","volume":"24","author":"Casonato","year":"2018","journal-title":"Haemophilia."},{"issue":"2","key":"2022050215222199400_B43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/1076029606299000","article-title":"Identifying carriers of type 2N von Willebrand disease: procedures and significance","volume":"13","author":"Casonato","year":"2007","journal-title":"Clin Appl Thromb Hemost."},{"issue":"4","key":"2022050215222199400_B44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1994.tb05127.x","article-title":"Biological effect of desmopressin in eight patients with type 2N (\u2018Normandy\u2019) von Willebrand disease","volume":"88","author":"Mazurier","year":"1994","journal-title":"Br J Haematol."},{"issue":"13","key":"2022050215222199400_B45","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood-2008-05-159699","article-title":"Intracellular cotrafficking of factor VIII and von Willebrand factor type 2N variants to storage organelles","volume":"113","author":"van den Biggelaar","year":"2009","journal-title":"Blood."},{"issue":"12","key":"2022050215222199400_B46","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1538-7836.2004.01023.x","article-title":"The roles of ADP and TXA in botrocetin\/VWF-induced aggregation of washed platelets","volume":"2","author":"Liu","year":"2004","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022050215222199400_B47","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1182\/blood-2008-02-140970","article-title":"Src family tyrosine kinase Lyn mediates VWF\/GPIb-IX-induced platelet activation via the cGMP signaling pathway","volume":"112","author":"Yin","year":"2008","journal-title":"Blood."},{"key":"2022050215222199400_B48","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0049-3848(10)70151-1","article-title":"Platelet adhesion to collagen","volume":"127","author":"Nuyttens","year":"2011","journal-title":"Thromb Res."},{"issue":"4","key":"2022050215222199400_B49","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI115144","article-title":"Thrombospondin-induced adhesion of human platelets","volume":"87","author":"Tuszynski","year":"1991","journal-title":"J Clin Invest."},{"issue":"3","key":"2022050215222199400_B50","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood-2004-12-4856","article-title":"Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13","volume":"107","author":"Bonnefoy","year":"2006","journal-title":"Blood."},{"issue":"7","key":"2022050215222199400_B51","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1538-7836.2006.01943.x","article-title":"Role of fibronectin assembly in platelet thrombus formation","volume":"4","author":"Cho","year":"2006","journal-title":"J Thromb Haemost."},{"issue":"3","key":"2022050215222199400_B52","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V66.3.724.724","article-title":"Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets","volume":"66","author":"Plow","year":"1985","journal-title":"Blood."},{"issue":"2","key":"2022050215222199400_B53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI111729","article-title":"Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III","volume":"75","author":"Houdijk","year":"1985","journal-title":"J Clin Invest."},{"issue":"3","key":"2022050215222199400_B54","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0005-2736(85)90275-5","article-title":"Characteristics of collagen-induced fibrinogen binding to human platelets","volume":"812","author":"Legrand","year":"1985","journal-title":"Biochim Biophys Acta."},{"issue":"3","key":"2022050215222199400_B55","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1006\/bbrc.1997.6554","article-title":"High shear stress attenuates agonist-induced, glycoprotein IIb\/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib\/IX is blocked","volume":"233","author":"Iijima","year":"1997","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"2022050215222199400_B56","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI115124","article-title":"The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress","volume":"87","author":"Ikeda","year":"1991","journal-title":"J Clin Invest."},{"issue":"3","key":"2022050215222199400_B57","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1172\/JCI116735","article-title":"Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease","volume":"92","author":"Murata","year":"1993","journal-title":"J Clin Invest."},{"issue":"10","key":"2022050215222199400_B58","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3324\/haematol.2019.235754","article-title":"Shear rate gradients promote a bi-phasic thrombus formation on weak adhesive proteins, such as fibrinogen in a VWF-dependent manner","volume":"105","author":"Receveur","year":"2020","journal-title":"Haematologica."},{"issue":"1","key":"2022050215222199400_B59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1172\/JCI113871","article-title":"Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate","volume":"83","author":"Weiss","year":"1989","journal-title":"J Clin Invest."},{"issue":"2","key":"2022050215222199400_B60","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1172\/JCI973","article-title":"Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions","volume":"101","author":"Goto","year":"1998","journal-title":"J Clin Invest."},{"issue":"28","key":"2022050215222199400_B61","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1016\/S0021-9258(19)76501-6","article-title":"Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III","volume":"262","author":"Pareti","year":"1987","journal-title":"J Biol Chem."},{"issue":"1","key":"2022050215222199400_B62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI115285","article-title":"150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen","volume":"88","author":"Rand","year":"1991","journal-title":"J Clin Invest."},{"issue":"9","key":"2022050215222199400_B63","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/9\/2778\/1894547\/advancesadv2021006353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/9\/2778\/1894547\/advancesadv2021006353.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T15:23:28Z","timestamp":1651505008000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/9\/2778\/483434\/A-novel-mouse-model-of-type-2N-VWD-was-developed"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,5,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006353","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]}}}